1. Home
  2. TK vs BBNX Comparison

TK vs BBNX Comparison

Compare TK & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

N/A

Current Price

$13.35

Market Cap

1.2B

ML Signal

N/A

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

N/A

Current Price

$16.65

Market Cap

997.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TK
BBNX
Founded
1973
2015
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
997.9M
IPO Year
1995
2025

Fundamental Metrics

Financial Performance
Metric
TK
BBNX
Price
$13.35
$16.65
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
★ $25.10
AVG Volume (30 Days)
417.9K
★ 1.1M
Earning Date
11-11-2026
10-27-2026
Dividend Yield
★ 7.51%
N/A
EPS Growth
N/A
★ 78.95
EPS
★ N/A
N/A
Revenue
N/A
★ $100,251,000.00
Revenue This Year
N/A
$25.22
Revenue Next Year
N/A
$47.09
P/E Ratio
$13.43
★ N/A
Revenue Growth
N/A
★ 53.94
52 Week Low
$8.67
$8.80
52 Week High
$15.90
$32.71

Technical Indicators

Market Signals
Indicator
TK
BBNX
Relative Strength Index (RSI) 42.89 47.09
Support Level $13.06 $15.92
Resistance Level $14.02 $18.20
Average True Range (ATR) 0.56 1.65
MACD -0.13 0.03
Stochastic Oscillator 34.00 31.59

Price Performance

Historical Comparison
TK
BBNX

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: